As of 2025-06-03, the Intrinsic Value of Shandong Weigao Group Medical Polymer Co Ltd (1066.HK) is 6.20 HKD. This 1066.HK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 5.39 HKD, the upside of Shandong Weigao Group Medical Polymer Co Ltd is 15.00%.
The range of the Intrinsic Value is 5.19 - 7.98 HKD
Based on its market price of 5.39 HKD and our intrinsic valuation, Shandong Weigao Group Medical Polymer Co Ltd (1066.HK) is undervalued by 15.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 5.19 - 7.98 | 6.20 | 15.0% |
| DCF (Growth 10y) | 6.31 - 9.53 | 7.49 | 38.9% |
| DCF (EBITDA 5y) | 12.32 - 16.55 | 14.45 | 168.0% |
| DCF (EBITDA 10y) | 12.21 - 17.35 | 14.67 | 172.2% |
| Fair Value | 2.47 - 2.47 | 2.47 | -54.26% |
| P/E | 9.92 - 12.13 | 11.10 | 105.9% |
| EV/EBITDA | 8.09 - 13.38 | 10.70 | 98.5% |
| EPV | 5.22 - 6.40 | 5.81 | 7.8% |
| DDM - Stable | 3.07 - 6.77 | 4.92 | -8.7% |
| DDM - Multi | 4.32 - 7.58 | 5.52 | 2.4% |
| Market Cap (mil) | 24,602.55 |
| Beta | 1.19 |
| Outstanding shares (mil) | 4,564.48 |
| Enterprise Value (mil) | 20,695.97 |
| Market risk premium | 5.98% |
| Cost of Equity | 10.90% |
| Cost of Debt | 4.28% |
| WACC | 9.80% |